Annual EBIT
-$36.74 M
-$17.93 M-95.33%
December 1, 2023
Summary
- As of February 27, 2025, SKYE annual earnings before interest & taxes is -$36.74 million, with the most recent change of -$17.93 million (-95.33%) on December 1, 2023.
- During the last 3 years, SKYE annual EBIT has fallen by -$30.89 million (-527.65%).
- SKYE annual EBIT is now -1888.81% below its all-time high of $2.05 million, reached on December 1, 2019.
Performance
SKYE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.61 M
+$3.84 M+51.59%
September 1, 2024
Summary
- As of February 27, 2025, SKYE quarterly earnings before interest & taxes is -$3.61 million, with the most recent change of +$3.84 million (+51.59%) on September 1, 2024.
- Over the past year, SKYE quarterly EBIT has stayed the same.
- SKYE quarterly EBIT is now -122.27% below its all-time high of $16.20 million, reached on June 1, 2019.
Performance
SKYE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$19.64 M
+$21.05 M+51.73%
September 1, 2024
Summary
- As of February 27, 2025, SKYE TTM earnings before interest & taxes is -$19.64 million, with the most recent change of +$21.05 million (+51.73%) on September 1, 2024.
- Over the past year, SKYE TTM EBIT has stayed the same.
- SKYE TTM EBIT is now -235.05% below its all-time high of $14.54 million, reached on March 1, 2020.
Performance
SKYE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SKYE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -95.3% | 0.0% | 0.0% |
| 3 y3 years | -527.6% | 0.0% | 0.0% |
| 5 y5 years | -92.4% | 0.0% | 0.0% |
SKYE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -374.1% | at low | -56.0% | +85.4% | -153.3% | +53.9% |
| 5 y | 5-year | -1888.8% | at low | -170.0% | +85.4% | -235.1% | +53.9% |
| alltime | all time | -1888.8% | at low | -122.3% | +85.4% | -235.1% | +53.9% |
Skye Bioscience EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.61 M(-51.6%) | -$19.64 M(-51.7%) |
| Jun 2024 | - | -$7.45 M(+62.7%) | -$40.68 M(+12.5%) |
| Mar 2024 | - | -$4.58 M(+14.6%) | -$36.15 M(-1.5%) |
| Dec 2023 | -$36.74 M(+95.3%) | -$4.00 M(-83.8%) | -$36.72 M(-13.7%) |
| Sep 2023 | - | -$24.65 M(+743.9%) | -$42.57 M(+104.4%) |
| Jun 2023 | - | -$2.92 M(-43.3%) | -$20.83 M(-1.4%) |
| Mar 2023 | - | -$5.15 M(-47.7%) | -$21.12 M(+12.2%) |
| Dec 2022 | -$18.81 M(+142.7%) | -$9.84 M(+237.4%) | -$18.81 M(+66.7%) |
| Sep 2022 | - | -$2.92 M(-9.1%) | -$11.28 M(+12.9%) |
| Jun 2022 | - | -$3.21 M(+12.8%) | -$10.00 M(+16.0%) |
| Mar 2022 | - | -$2.84 M(+23.0%) | -$8.62 M(+11.2%) |
| Dec 2021 | -$7.75 M(+32.4%) | -$2.31 M(+41.9%) | -$7.75 M(+14.7%) |
| Sep 2021 | - | -$1.63 M(-11.1%) | -$6.76 M(+8.3%) |
| Jun 2021 | - | -$1.83 M(-7.2%) | -$6.24 M(+10.4%) |
| Mar 2021 | - | -$1.98 M(+50.1%) | -$5.65 M(-3.4%) |
| Dec 2020 | -$5.85 M(-385.0%) | -$1.32 M(+18.1%) | -$5.85 M(-1054.7%) |
| Sep 2020 | - | -$1.11 M(-10.7%) | $613.20 K(-121.1%) |
| Jun 2020 | - | -$1.25 M(-42.7%) | -$2.91 M(-120.0%) |
| Mar 2020 | - | -$2.18 M(-142.2%) | $14.54 M(+607.9%) |
| Dec 2019 | $2.05 M(-110.8%) | $5.15 M(-211.2%) | $2.05 M(-122.2%) |
| Sep 2019 | - | -$4.63 M(-128.6%) | -$9.26 M(+37.7%) |
| Jun 2019 | - | $16.20 M(-210.5%) | -$6.73 M(-73.7%) |
| Mar 2019 | - | -$14.66 M(+137.7%) | -$25.59 M(+34.0%) |
| Dec 2018 | -$19.10 M | -$6.17 M(+194.2%) | -$19.10 M(+40.8%) |
| Sep 2018 | - | -$2.10 M(-21.2%) | -$13.56 M(+13.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$2.66 M(-67.5%) | -$11.94 M(+19.6%) |
| Mar 2018 | - | -$8.18 M(+1201.3%) | -$9.99 M(+223.0%) |
| Dec 2017 | -$3.09 M(-2.7%) | -$628.30 K(+30.9%) | -$3.09 M(+48.5%) |
| Sep 2017 | - | -$480.10 K(-31.5%) | -$2.08 M(-15.3%) |
| Jun 2017 | - | -$701.20 K(-45.3%) | -$2.46 M(-24.1%) |
| Mar 2017 | - | -$1.28 M(-435.7%) | -$3.24 M(+2.0%) |
| Dec 2016 | -$3.18 M(-26.4%) | $382.00 K(-144.6%) | -$3.18 M(-32.6%) |
| Sep 2016 | - | -$856.10 K(-42.2%) | -$4.71 M(-0.8%) |
| Jun 2016 | - | -$1.48 M(+21.4%) | -$4.75 M(+2.7%) |
| Mar 2016 | - | -$1.22 M(+5.7%) | -$4.63 M(+7.2%) |
| Dec 2015 | -$4.32 M(+58.0%) | -$1.15 M(+28.8%) | -$4.32 M(-11.2%) |
| Sep 2015 | - | -$896.30 K(-33.9%) | -$4.86 M(+0.8%) |
| Jun 2015 | - | -$1.36 M(+49.1%) | -$4.82 M(+39.5%) |
| Mar 2015 | - | -$909.80 K(-46.5%) | -$3.46 M(+35.0%) |
| Dec 2014 | -$2.73 M(>+9900.0%) | -$1.70 M(+98.3%) | -$2.56 M(+198.6%) |
| Sep 2014 | - | -$857.60 K(<-9900.0%) | -$858.30 K(>+9900.0%) |
| Jul 2014 | - | $8500.00(-164.4%) | -$5600.00(-62.4%) |
| Apr 2014 | - | -$13.20 K(-430.0%) | -$14.90 K(-809.5%) |
| Jan 2014 | - | $4000.00(-181.6%) | $2100.00(-250.0%) |
| Oct 2013 | -$1600.00(-133.3%) | -$4900.00(+512.5%) | -$1400.00(-116.7%) |
| Jul 2013 | - | -$800.00(-121.1%) | $8400.00(-9.7%) |
| Apr 2013 | - | $3800.00(+660.0%) | $9300.00(+82.4%) |
| Jan 2013 | - | $500.00(-89.8%) | $5100.00(+10.9%) |
| Oct 2012 | $4800.00 | $4900.00(+4800.0%) | $4600.00(-1633.3%) |
| Jul 2012 | - | $100.00(-125.0%) | -$300.00(-25.0%) |
| Apr 2012 | - | -$400.00 | -$400.00 |
FAQ
- What is Skye Bioscience annual earnings before interest & taxes?
- What is the all time high annual EBIT for Skye Bioscience?
- What is Skye Bioscience annual EBIT year-on-year change?
- What is Skye Bioscience quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Skye Bioscience?
- What is Skye Bioscience quarterly EBIT year-on-year change?
- What is Skye Bioscience TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Skye Bioscience?
- What is Skye Bioscience TTM EBIT year-on-year change?
What is Skye Bioscience annual earnings before interest & taxes?
The current annual EBIT of SKYE is -$36.74 M
What is the all time high annual EBIT for Skye Bioscience?
Skye Bioscience all-time high annual earnings before interest & taxes is $2.05 M
What is Skye Bioscience annual EBIT year-on-year change?
Over the past year, SKYE annual earnings before interest & taxes has changed by -$17.93 M (-95.33%)
What is Skye Bioscience quarterly earnings before interest & taxes?
The current quarterly EBIT of SKYE is -$3.61 M
What is the all time high quarterly EBIT for Skye Bioscience?
Skye Bioscience all-time high quarterly earnings before interest & taxes is $16.20 M
What is Skye Bioscience quarterly EBIT year-on-year change?
Over the past year, SKYE quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Skye Bioscience TTM earnings before interest & taxes?
The current TTM EBIT of SKYE is -$19.64 M
What is the all time high TTM EBIT for Skye Bioscience?
Skye Bioscience all-time high TTM earnings before interest & taxes is $14.54 M
What is Skye Bioscience TTM EBIT year-on-year change?
Over the past year, SKYE TTM earnings before interest & taxes has changed by $0.00 (0.00%)